Safety and efficacy of low-dose intravenous immune globulin (IVIG) treatment for infants and children with immune thrombocytopenic purpura. Low-Dose IVIG Study Group (Q33499653)
scientific article
Language:
Current Data About Safety and efficacy of low-dose intravenous immune globulin (IVIG) treatment for infants and children with immune thrombocytopenic purpura. Low-Dose IVIG Study Group
(P31) (Q13442814)
(P248)
(P698) 9201140
(P813) Thursday, July 27, 2017

(P50) (Q1680075)
(P1545) 2
(P1932) Bussel JB
(P248)
(P698) 9201140
(P813) Thursday, July 27, 2017

(Q106606185)
(P1545) 1
(P1932) Warrier I
(P248)
(P698) 9201140
(P813) Thursday, July 27, 2017

(P304) 197-201
(P248)
(P698) 9201140
(P813) Thursday, July 27, 2017

(P407) (Q1860)
(P887)

(P433) 3
(P248)
(P698) 9201140
(P813) Thursday, July 27, 2017

(P478) 19
(P248)
(P698) 9201140
(P813) Thursday, July 27, 2017

(P577) Thursday, May 1, 1997
(P248)
(P698) 9201140
(P813) Thursday, July 27, 2017

(P921) (Q585285)
(P887)

(P1433) (Q15761808)
(P248)
(P698) 9201140
(P813) Thursday, July 27, 2017

(P1476) "Safety and efficacy of low-dose intravenous immune globulin (IVIG) treatment for infants and children with immune thrombocytopenic purpura. Low-Dose IVIG Study Group" (language: en)
(P248)
(P698) 9201140
(P813) Thursday, July 27, 2017

(P2093) Valdez L
(P1545) 3
(P248)
(P698) 9201140
(P813) Thursday, July 27, 2017

Barbosa J
(P1545) 4
(P248)
(P698) 9201140
(P813) Thursday, July 27, 2017

Beardsley DS
(P1545) 5
(P248)
(P698) 9201140
(P813) Thursday, July 27, 2017

other details